- Home
- NNOX vs HQL Comparison
NNOX vs HQL Comparison
Compare NNOX & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- HQL
- Stock Information
- Founded
- NNOX 2011
- HQL 1992
- Country
- NNOX Israel
- HQL United States
- Employees
- NNOX N/A
- HQL N/A
- Industry
- NNOX Medical Electronics
- HQL Investment Managers
- Sector
- NNOX Health Care
- HQL Finance
- Exchange
- NNOX Nasdaq
- HQL Nasdaq
- Market Cap
- NNOX 330.6M
- HQL 368.7M
- IPO Year
- NNOX 2020
- HQL N/A
- Fundamental
- Price
- NNOX $5.23
- HQL $12.34
- Analyst Decision
- NNOX Strong Buy
- HQL
- Analyst Count
- NNOX 2
- HQL 0
- Target Price
- NNOX $9.50
- HQL N/A
- AVG Volume (30 Days)
- NNOX 912.2K
- HQL 120.9K
- Earning Date
- NNOX 05-22-2025
- HQL 01-01-0001
- Dividend Yield
- NNOX N/A
- HQL 11.56%
- EPS Growth
- NNOX N/A
- HQL N/A
- EPS
- NNOX N/A
- HQL 0.79
- Revenue
- NNOX $11,545,000.00
- HQL N/A
- Revenue This Year
- NNOX $105.67
- HQL N/A
- Revenue Next Year
- NNOX $177.95
- HQL N/A
- P/E Ratio
- NNOX N/A
- HQL $17.08
- Revenue Growth
- NNOX 15.32
- HQL N/A
- 52 Week Low
- NNOX $3.75
- HQL $11.34
- 52 Week High
- NNOX $11.00
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- NNOX 49.72
- HQL 50.10
- Support Level
- NNOX $4.97
- HQL $12.12
- Resistance Level
- NNOX $5.62
- HQL $12.53
- Average True Range (ATR)
- NNOX 0.29
- HQL 0.24
- MACD
- NNOX -0.03
- HQL 0.00
- Stochastic Oscillator
- NNOX 40.57
- HQL 51.84
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.